Literature DB >> 11472267

The epothilones, eleutherobins, and related types of molecules.

S J Stachel1, K Biswas, S J Danishefsky.   

Abstract

Taxol is currently one of the most effective anticancer agents available. However, limitations due to multidrug-resistance (MDR) susceptibility and lack of aqueous solubility render it less than an ideal drug. These limitations, coupled with taxol's unique mechanism of tumor inhibition, involving the stabilization of microtubule assembly, have spurred the search for more effective chemotherapeutic agents. This review will discuss the chemistry and biology of some of the most promising new molecules with "taxol-like" activity. The extended family of microtubule-stabilizing agents now includes the epothilones, eleutherobins, discodermolide, laulimalide and WS9885B. The epothilones have emerged as one of the most exciting new candidates for detailed structure-activity-related studies. A review of our efforts in the synthetic and biological aspects of this research is presented, as are the latest developments reported from other laboratories in academia and the pharmaceutical industry. The synthesis and structure-activity studies of eleutherobins, as well as recent progress with discodermolide, laulimalide and WS9885B are also reviewed. An abundance of exciting advances in chemistry and biology have emerged from these studies, and it is hoped that it will ultimately result in the development of new and more effective chemotherapeutic agents in the fight against cancer.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11472267     DOI: 10.2174/1381612013397410

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  4 in total

1.  Synthetic studies of microtubule stabilizing agent peloruside A: an asymmetric synthesis of C10-C24 segment.

Authors:  Arun K Ghosh; Jae-Hun Kim
Journal:  Tetrahedron Lett       Date:  2003-09-13       Impact factor: 2.415

Review 2.  Beyond taxanes: a review of novel agents that target mitotic tubulin and microtubules, kinases, and kinesins.

Authors:  Michael R Harrison; Kyle D Holen; Glenn Liu
Journal:  Clin Adv Hematol Oncol       Date:  2009-01

3.  From nature to the laboratory and into the clinic.

Authors:  K C Nicolaou; Jason S Chen; Stephen M Dalby
Journal:  Bioorg Med Chem       Date:  2008-11-06       Impact factor: 3.641

4.  Iron complexation to oxygen rich marine natural products: a computational study.

Authors:  Thomas J Manning; Jimmy Williams; Joey Jarrard; Teresa Gorman
Journal:  Mar Drugs       Date:  2010-01-04       Impact factor: 5.118

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.